Hospital PMI: Economic activity in the hospital subsector grew in March for the seventh consecutive month after contracting twice in the previous four-month period, with 35 consecutive months of growth prior to that, say the nation's hospital supply executives in the latest Hospital ISM® Report On Business®.
The report offers detailed insights on EPKINLY and its market forecast for Diffuse Large B-cell lymphoma (DLBCL) has been made available, revealing crucial data intended for healthcare professionals and stakeholders.
The global healthcare industry observes an escalation in efficiency and effectiveness in wound management techniques, as this report examines the expansive landscape of the Global Surgical Sutures Market from 2024 to 2033.
Global Wilms Tumor Treatment Market has valued at USD 1.24 billion in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 4.40% through 2028
The dermatology lasers market size is expected to grow by USD 729.65 million from 2023 to 2028. In addition, the momentum of the market will progress at a CAGR of 7.4% during the forecast period, according to Technavio Research. The market is categorized by End-user (Dermatology clinics, Hospitals, and Others), Product (Solid-state dermatology lasers, Gas dermatology lasers, and Pulsed dye dermatology lasers), and Geography (North America, Europe, Asia, and Rest of World (ROW)).
The DNA Data storage market is projected to grow from USD 76 million in 2024 and is expected to reach USD 3,348 million by 2030, growing at a CAGR of 87.7% from 2024 to 2030.
The market is segmented by end-user (pharmaceutical and biotechnology companies and other healthcare service providers), product (tray-style freeze dryer, manifold freeze dryer, and rotary freeze dryer), and geography (North America, Europe, Asia, and Rest of World (ROW)).
Developed by Janssen Biotech, the blockbuster therapeutic antibody STELARA (INN: ustekinumab) is an approved human interleukin-12 and interleukin-23 antagonist indicated for the treatment of moderate to severe plaque psoriasis in adults and pediatric patients (6 years or older) who are candidates for phototherapy or systemic therapy, active psoriatic arthritis in adults, as well as for adult patients with moderately to severely active Crohn's disease and moderately to severely active ulcerative colitis. Stelara was approved in the US and EU in 2009. The Stelara patent expires September 2023 in the United States.
The global market for Colonoscopy Devices estimated at US$1.6 Billion in the year 2022, is projected to reach a revised size of US$2.2 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2022-2030.
By using this website you agree to accept Medical Device News Magazine Privacy Policy
